添加微信 添加微信
添加微信
首页: 全球医药政策

意大利-Chiesi

时间:2021-10-21 17:35:25 来源:康安医药咨询 作者:康安医药咨询

We are an international company based in Parma, with 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas. With a turnover of more than €1.571 billion sales we are among the top 50 pharmaceutical companies in the world. Our production sites are in Parma, Italy, Blois (France) and Santana De Parnaiba (Brazil). Its R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham (UK) and the R&D team from the newly-acquired Danish company Zymenex, integrate their efforts to advance Chiesi’s pre-clinical, clinical and registration programmes. We export to more than 70 countries with a direct presence in 26. The Chiesi Group employs approximately 4,813 people, 671 of whom are dedicated to R&D activities and 700 of whom work at production sites in Italy, France and Brazil.

Phone: 3905212791 Fax: 390521774468 E-mail: https://www.chiesi.com/en/contacts/
Web: https://www.chiesi.com/en/
Add:26/A, Via Palermo (Main entrance: 1, Via Giacomo Chiesi)

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章